The 11th annual Raw Science Film Festival took place this past weekend in New York City. We were lucky enough to be invited and had the honor of interviewing Dr. Larry Corey in-person. He is a renowned expert in virology, immunology and vaccine development who was featured throughout the film “Ending HIV: The Journey to a Vaccine”. The film won the Jury Award for Best Professional Documentary Feature at the festival.
While at the festival our host/producer Kira Dineen accepted the Backstage Best Actor Award (Female) on Devin Sidell’s behalf. You may rem...
The 11th annual Raw Science Film Festival took place this past weekend in New York City. We were lucky enough to be invited and had the honor of interviewing Dr. Larry Corey in-person. He is a renowned expert in virology, immunology and vaccine development who was featured throughout the film “Ending HIV: The Journey to a Vaccine”. The film won the Jury Award for Best Professional Documentary Feature at the festival.
While at the festival our host/producer Kira Dineen accepted the Backstage Best Actor Award (Female) on Devin Sidell’s behalf. You may remember her from Episode #360 where we talked with her about her film “Love, Danielle” which is the first scripted feature film to explore the very real struggles of living with a BRCA gene mutation.
The Guest:
Dr. Larry Corey is the former president and director of Fred Hutch Cancer Center. His research focuses on herpes viruses, HIV, the novel coronavirus and other viral infections, including those associated with cancer. For 25 years Dr. Corey has led the HIV Vaccine Trials Network (HVTN), the largest international research network focused on developing a safe and effective vaccine against HIV. In 2020 he was selected by Dr. Anthony Fauci to lead the CoVID Prevention Network to run the clinical trials for COVID-19 under Operation Warpspeed. The scientific work on HIV made it possible to achieve a COVID vaccine in record time. In turn, COVID vaccines gave us mRNA technologies and the ability to speed up vaccine development and save more lives.
“Ending HIV: The Journey to a Vaccine” Documentary:
This powerful and timely documentary masterfully chronicles one of the most significant scientific pursuits of our era, spanning decades of research and resilience.
Since the early 1980s, scientists, researchers, community organizers, faith leaders, and countless organizations have poured their lives into understanding and battling HIV — the most complicated virus medicine has ever faced.
When the HIV Vaccine Trials Network (HVTN) was formed in the 1990s, an unprecedented global collaboration took shape. But until now, the tireless work across countries, races, genders, and disciplines had never been fully narrated on screen.
On This Episode We Discuss:
In this in-person conversation, Dr. Larry Corey discusses his extensive experience in vaccine development, particularly focusing on the challenges of creating an HIV vaccine compared to COVID-19. He highlights the genetic diversity of HIV, the evolution of vaccine strategies, and the importance of community engagement in research. Dr. Corey also emphasizes the impact of HIV research on broader scientific fields and addresses the ongoing issue of vaccine skepticism in public health.
- HIV's genetic diversity complicates vaccine development significantly.
- Understanding immune evasion strategies is crucial for creating effective vaccines.
- The evolution of vaccine strategies has shifted focus from T cells to B cells.
- Infrastructure built for HIV research facilitated rapid COVID-19 vaccine development.
- Community engagement is essential for successful vaccine trials and public trust.
- HIV research has led to advancements in other areas of medicine and science.
- Continued funding for HIV research is critical for future breakthroughs.
- Vaccine skepticism poses a significant challenge to public health initiatives.
- Engaging with communities can help combat misinformation about vaccines.
- An HIV vaccine may be achievable within the next few years.
Relevant Resources:
- Watch the full documentary “Ending HIV: Journey to a Vaccine” on their website here
- Learn about the HIV Vaccine Trial Network here
- Learn more about the science behind HIV research here
- See the road of the HIV milestones here
- Find out if there's a study clinic near you here, their studies are conducted at over 40 research sites across the United States
- Find out more about volunteering for a study here
- Access information about The Fred Hutch Cancer Center here
- Check out the Raw Science Film Festival here
- Brand new paper published on October 25th (the day we recorded) that Dr. Corey referenced.
- Youyi Fong, Yunda Huang, Ying Huang, Wayne Woo, Alice McGarry, Germán Áñez, Lisa M Dunkle, Iksung Cho, Christopher R Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Christos J Petropoulos, Andrew Leith, Deanne Haugaard, William Webb, Yiwen Lu, Chenchen Yu, Lindsay N Carpp, April K Randhawa, Michele P Andrasik, James G Kublin, Julia Hutter, Maryam Keshtkar-Jahromi, Tatiana H Beresnev, Carina A Rodriguez, Milagritos Tapia, Christine B Turley, Carmen D Zorrilla, Stuart H Cohen, Susan E Kline, Elizabeth Barranco, Lawrence Corey, Kathleen M Neuzil, Dean Follmann, Julie A Ake, Cynthia L Gay, Karen L Kotloff, Thomas Jones, Richard A Koup, Ruben O Donis, Peter B Gilbert, on behalf of the Immune Assays Team, the Coronavirus Vaccine Prevention Network (CoVPN)/2019nCoV-301 Principal Investigators and Study Team, and the United States Government (USG)/CoVPN Biostatistics Team, Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine, Clinical Infectious Diseases, 2025;, ciaf558, https://doi.org/10.1093/cid/ciaf558
Relevant DNA Today Podcast Episode:
#67 Daniel DeFabio on Disorder: The Rare Disease Film Festival
#110 Gattaca, 22 Years Later
#151: Richard Michelmore and Brad Pollock on COVID-19 Variants
#154 Kenneth Kovan & David Berd on Haptenized Vaccines
#306 NIH’s Dr. Francis Collins’ Leadership in the Human Genome Project and COVID-19
#328 Breakthrough Biotech: CAR-Ts for Solid Tumors & Engineered Bacteria for Rare Diseases
#360 Hereditary Breast Cancer on the Big Screen with “Love, Danielle”
#363 ASHG 2025 Recap: AI Diagnostics, Genetics Publications & Losing NIH Funding
We will see many of you next week in Seattle for the National Society of Genetic Counselors (NSGC) annual conference. If you are attending and want to be featured on the show, meet us at the end of “Passport to Prizes” where we will record quick sound bites on what you learned at the conference to be included in our NSGC recap episode.
Get ready, genetic nerds—another brand-new episode of DNA Today drops this Friday! You can always count on us to deliver fresh content every Friday.
While you wait, why not dive into our library of over 360 episodes? Binge them all on Apple Podcasts, Spotify, our website, or wherever you love to listen—just search “DNA Today.”
Prefer watching? We’ve got you covered! For the past four years, we’ve been recording episodes with video, including some filmed at the iconic NBC Universal Stamford Studios. Check them out on our YouTube channel!
DNA Today is hosted and produced by Kira Dineen, MS, LCGC, CG(ASCP)CM . Our Video Lead is Amanda Andreoli. Our Social Media Lead Liv Davidson. And our logo Graphic Designer is Ashlyn Enokian, MS, CGC.
See what else we are up to on Instagram, X (Twitter), BluSky, Threads, LinkedIn, Facebook, YouTube and our website, DNAToday.com. Questions/inquiries can be sent to info@DNAtoday.com.
